Global Apheresis Market Insights Forecasts to 2030

• The Apheresis Market Size was valued at USD 2.10 Billion in 2021.
• The Market is Growing at a CAGR of 11.15% from 2021 to 2030
• The Worldwide Apheresis Market is expected to reach USD 6.5 Billion by 2030
• Asia Pacific is expected to Grow the fastest during the forecast period

The Global Apheresis Market Size is expected to reach USD 6.5 Billion by 2030, at a CAGR of 11.15% during the forecast period 2021 to 2030.

Apheresis is the removal of blood from the body of the donor, withdrawal of one or more than one components of blood like white blood cells, platelets, plasma, as well as transfusion of the rest of the blood back into the donor during or the end of the procedure. In this case, the entire blood from the body of the patient or the body of the donor is transferred through the help of an instruments which is made as a centrifuge in which all the components are segmented.

COVID 19 Impact on Apheresis Market

The outbreak of COVID 19 has created a positive impact on the global apheresis market growth because the market has boosted the healthcare system across the world. Due to the pandemic, certain coagulation parameters like fibrinogen, platelet count, prothrombin time (PT), D-dimmer, activated partial thromboplastin time (aPTT) are known to be the complications in the people who were affected which is why the plasma therapy treatment was given to the infected people. In addition, the convalescent plasma therapy is widely used for the people who are affected due to COVID 19. As per the article published in Lancet journal, between 28 May 2020, and 15 June 2021, around 11558 out of 16287 patients were recovered and were eligible to receive convalescent plasma. This therapy includes plasma collection from the body of the patient who has been recovered from the infection. Hence, such factors are positively affecting the growth of the global apheresis market over the pandemic.

Key Market Drivers

Rising cases of various health issues to propel the market growth

The increasing cases of chronic health ailments such as autoimmune diseases and cancer is anticipated to expand the market. As per the National Stem Cell Foundation (NSCF), more than 80 autoimmune diseases are the major causes of deaths across the world. In fact, in the US, the third most common reasons of deaths is the autoimmune diseases. As pe the Johns Hpkins Medicine Pathology, around 3%  of people across the US are suffering from autoimmune diseases. Thus, therapeutic plasma exchange or TPE are done to treat such health issues.

Key Market Challenges

The less number of skilled people, rising blood contamination, as well as higher cost involved in apheresis processes are hampering the overall growth of the market.

Market Segmentation

Product Insights

The disposable apheresis kit segment held the highest market share over the forecast period.

On the basis of product, the global apheresis market is segmented into disposable apheresis kits and devices. Among these, the disposable apheresis kits is dominating the market with the highest market share over the forecast period due to the increasing advancement in the making of  blood bags, tubing and disposable kits. Apart from this, the rise in the demand for automated component separation processes in the developed countries are propelling the market growth.

The device segment, on the other hand is witnessing the fastest market growth over the forecast period owing to various factors such as advanced healthcare infrastructure, increasing demand for automated blood component separators, and increasing number of blood donors. In addition, the launch of various advanced and sophisticated apheresis machines and increasing demand in developing nations are also driving the segmental growth.

Application Insights

The neurology segment is dominating the market with the largest market share over the forecast period.

On the basis of application, the global apheresis market is bifurcated into haematology, renal diseases, neurology, and others. Among these, the neurology segment is dominating the market with the largest market share over the forecast period. The main reason behind the growth is the need of therapeutic devices to treat the increasing number of neurological issues such as autoimmune neurological disorders and multiple sclerosis. According to the Atlas of MS, multiple sclerosis has impacted around 2.8 million people across the world. This disease has mostly affected women as compared to men. Moreover, increasing initiatives taken by the government for research and development are boosting the segmental growth.

The haematology segment is anticipated to witness a rapid growth  owing to the increasing cases of blood disorders among people. As per the America National Red Cross, about 90,000 to 1,00,000 people are affected from sickle cell disease in the US which is why they need blood transfusions throughout their entire lives.

Procedure Insights

The plasmapheresis accounted the largest market share over the forecast period.

Based on the procedure, the global apheresis market is segmented into plasmapheresis, plateletpheresis, LDL apheresis, leukapheresis, photopheresis, erythrocytapheresis, others. Among these, the plasmapheresis segment is dominating the market with the largest market share over the forecast period. A plasma based medicines are delivered to the people who have weak immune systems with an aim to increase infection in the body. The main reason behind the growth of the segment is the increasing cases of blood based issues which results in the increasing demand for plasma based therapies.

The leukapheresis, on the other hand is anticipated to witness a significant growth over the forecast period owing to rising prevalence of cancer specifically, prostate and breast cancel and leukemia. For instance, in January 2022, as per the American Cancel Society, there are around 60,650 ne cases of leukemia in the US among which 24,000 people died in 2022 due to leukemia.

Technology Insights

The centrifugation device segment holds the largest revenue share over the forecast period.

On the basis of technology, the apheresis market is categorized into membrane filtration and centrifugation. Among these, the centrifugation segment holds the largest revenue share over the forecast period. It provides simpler, faster and accurate results than the membrane filtration which contributes the segmental growth. In addition, the increasing demand for automated apheresis system is boosting the growth of centrifugation device segment. In fact, market players have started to create technologically advanced devices which improve efficiency of the product. For instance, Haemonetics Corp has launched NexSys PCS which is an automated system that boosts efficiency while boosting the compliance and quality in plasma collection centers.

Regional Insights

North America is dominating the market with the largest market share over the forecast period.

North America is dominating the global apheresis market owing to the increasing cases of blood related issues like metabolic diseases, kidney diseases, and neurological disorders. Apart from this, the rising demand for blood components are also the other factors which are driving the regional market growth. As per the American National Red Cross, about 6.8 million people donate blood every year. Hence, an increase in the number of blood transfusions and rising donation camps are driving the US market.

On the other hand, the Asia Pacific market is anticipated to witness the fastest market growth over the forecast period due to the increasing cases of blood disorders which need platelet and plasma transfusion in the developing countries like China and India. Moreover, the development in the healthcare infrastructure and rise in the number of healthcare practitioners are booming the Asia Pacific region.

Recent Developments

• In October 2020, Haemonetics has received US FDA 510(k) approval for its NexSys PCS sytem having Persona technology.

• In July 2022, Eliaz Therapeutics and Terumo Blood and Cell Technologies created a novel therapeutic apheresis therapy for acute kidney injury.

List of Key Companies

• Haemonetics Corporation
• Fresenius Kabi
• Terumo BCT, Inc
• Asahi Kasei Medical Co., Ltd
• Kaneka Corporation
• Kawasumi Laboratories Inc
• Cerus Corporation
• B. Braun Melsungen AG
• Nikkiso Co., Ltd
• Charles River Laboratories International, Inc.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2019 to 2030. Spherical Insights has segmented the global Apheresis Market based on the below-mentioned segments:

Apheresis Market, Product Analysis

• Disposable Apheresis Kits
• Device

Apheresis Market, Procedure Analysis

• Plasmapheresis
• LDL apheresis
• Leukapheresis
• Plateletpheresis
• Photopheresis
• Erythrocytapheresis
• Others

Apheresis Market, Application Analysis

• Renal diseases
• Neurology
• Haematology
• Others

Apheresis Market, Technology Analysis

• Membrane Filtration
• Centrifugation

Apheresis Market, Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of Middle East & Africa